Latham & Watkins and Wilson Sonsini Goodrich & Rosati advised Fractyl Health on the transaction, and Goodwin Procter advised the underwriters. Fractyl Health (Nasdaq: GUTS) announced the...
Fractyl Health’s $110 Million Initial Public Offering
RealBlocks’ $10 Million Series A Financing Extension
Latham & Watkins advised RealBlocks on the financing. RealBlocks announced a $10 million extension of its Series A financing, bringing its total investment amount to $20.7...
Immuneering’s $30 Million Common Shares Offering
Latham & Watkins represented Immuneering in the offering, while Sidley Austin represented the underwriters involved. Immuneering Corporation (Nasdaq: IMRX) announced the pricing of its underwritten offering...
IXL Learning’s Acquisition of Teachers Pay Teachers
Latham & Watkins served as legal counsel to IXL Learning, and Choate Hall served as legal counsel to Teachers Pay Teachers. IXL Learning announced that it has...
Heru’s $6 Million Seed Financing Round
Latham & Watkins represented Heru in the transaction. Heru, an AI-based tax platform that simplifies the tax-filing process and provides intelligent insights for future filings, announced a...
Kate Farms’ $75 Million Series C Funding Round
Latham & Watkins LLP represented Kate Farms in the transaction. Kate Farms, a market leader in bringing plant-based nutrition into healthcare, has announced the completion of its...
IXL Learning’s Acquisition of Emmersion
Latham & Watkins LLP advised IXL Learning in the transaction. IXL Learning, developer of personalized learning products used by millions of people worldwide, has announced it...
Virtual Incision Corporation’s $46 Million Funding Round
Latham & Watkins represented Baird Capital and Endeavour Vision in the transaction. Virtual Incision Corporation, a medical device company pioneering first-of-its-kind miniaturized robots for laparoscopic surgery,...
GAIA’s US$50 Million Financing Series C Round
Latham & Watkins represented Gaia Design, while Morrison & Foerster advised SoftBank Latin America Fund on the deal. SoftBank Latin America Fund led the Series C US$50...
Immuneering’s US$129.4 Million IPO
Sidley Austin advised the underwriters on the deal, while Choate and Latham & Watkins assisted Immuneering Corporation. Immuneering Corporation (Nasdaq: IMRX), a biopharmaceutical company advancing a...
Saranas’ $12.8 Million Series B Investment
Wilson Sonsini Goodrich & Rosati advised Saranas on the deal, while Latham & Watkins represented Baird Capital. Houston, Texas-based Saranas announced a $12.8 million Series B...
Fractyl Health’s $100 Million Series F Financing
Latham & Watkins LLP represented Fractyl Health in the transaction. Fractyl Health, a life sciences company dedicated to developing novel therapeutic interventions aimed at reversing the...